Difference between revisions of "Team:AFCM-Egypt"
Aymanshafei (Talk | contribs) |
Aymanshafei (Talk | contribs) |
||
| (13 intermediate revisions by 2 users not shown) | |||
| Line 12: | Line 12: | ||
<meta name="viewport" content="width=device-width, initial-scale=1.0"> | <meta name="viewport" content="width=device-width, initial-scale=1.0"> | ||
<style> | <style> | ||
| − | + | .HOME a {border: 1px solid #fff; | |
| − | .HOME {border: 1px solid #fff; | + | |
background: rgba(255,255,255, 0.3) !important} | background: rgba(255,255,255, 0.3) !important} | ||
| Line 163: | Line 162: | ||
<div class="container section-wrapper" style="padding-top:0px !important;width:90%"> | <div class="container section-wrapper" style="padding-top:0px !important;width:90%"> | ||
<div class="col-md-12 text-center"> | <div class="col-md-12 text-center"> | ||
| − | <video | + | <video autoplay controls loop style="width:85%;height:85%"> |
<source src="https://static.igem.org/mediawiki/2017/8/88/Final_vid.mp4" type="video/mp4"> | <source src="https://static.igem.org/mediawiki/2017/8/88/Final_vid.mp4" type="video/mp4"> | ||
</video> | </video> | ||
| Line 174: | Line 173: | ||
<div class="col-md-6 text-center" style="float: none;height: auto ; width: 90%; margin: auto; background-color: rgba(0, 0, 0, 0.4);"> | <div class="col-md-6 text-center" style="float: none;height: auto ; width: 90%; margin: auto; background-color: rgba(0, 0, 0, 0.4);"> | ||
<p><img style="float: right;" src="https://static.igem.org/mediawiki/2017/d/d4/CRISPR_PNG.png" alt="" width="679" height="988" /></p> | <p><img style="float: right;" src="https://static.igem.org/mediawiki/2017/d/d4/CRISPR_PNG.png" alt="" width="679" height="988" /></p> | ||
| − | + | <h3 dir="ltr" style="text-align: left;"><span style="font-size: 20pt; color: #ffffff;">Competing endogenous RNA network : Potential entrants to gene editing in Hepatocellular Carcinoma</span><br /><br /><br /> | |
| + | <h3 class="text-center" style="text-align: center;"><br /><br /><span style="font-size: 14pt; color: #ffffff;">Abstract</span></h3> | ||
<p style="text-align: left;"><span style="font-size: 14pt; color: #ffffff;"> </span></p> | <p style="text-align: left;"><span style="font-size: 14pt; color: #ffffff;"> </span></p> | ||
| − | + | <span style="font-size: 14pt; color: #ffffff;">Hepatocellular Carcinoma (HCC) is the leading cause of cancer deaths worldwide & ranked first among cancers in males and next to breast cancer among females in</span><span style="font-size: 14pt; color: #ffffff;"> Egypt based upon results of National Cancer Registry Program of Egypt. "Grabbing the problem from the roots" is the best way to decently describe the use of CRISPR, a special gene editing technique that we will be using to modulate a certain circRNA and adjust its gene expression, which is down-regulated in hepatocellular carcinoma. This in consequence modifies miRNA expression thus amending the mRNA gene expression; which is the visible problem in our trials. This will lead us to adopt a novel strategy for miRNA suppression by using circRNAs. This is accomplished by utilizing a synthetic circuit to give rise to a springboard in our battle against cancer.</span><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /></h3> | |
</div> | </div> | ||
</div> | </div> | ||
| Line 205: | Line 205: | ||
</li> | </li> | ||
<li class="afcmslide"> | <li class="afcmslide"> | ||
| − | |||
<img src="https://static.igem.org/mediawiki/2017/3/3b/4-AFCM-Egypt-sponsers-Nationel_Research.png" style="width: 150px;padding-right: 15px;"> | <img src="https://static.igem.org/mediawiki/2017/3/3b/4-AFCM-Egypt-sponsers-Nationel_Research.png" style="width: 150px;padding-right: 15px;"> | ||
<img src="https://static.igem.org/mediawiki/2017/6/67/7-AFCM-Egypt-sponsers-Image-2.jpeg" style="width: 160px;padding-right: 15px;"> | <img src="https://static.igem.org/mediawiki/2017/6/67/7-AFCM-Egypt-sponsers-Image-2.jpeg" style="width: 160px;padding-right: 15px;"> | ||
| Line 218: | Line 217: | ||
</section> | </section> | ||
<button id="myBtn" title="Go to top"><i class="fa fa-arrow-up fa-3x"></i></button> | <button id="myBtn" title="Go to top"><i class="fa fa-arrow-up fa-3x"></i></button> | ||
| − | + | ||
<script> | <script> | ||
$(document).ready(function() { | $(document).ready(function() { | ||
Latest revision as of 20:11, 31 October 2017
Competing endogenous RNA network : Potential entrants to gene editing in Hepatocellular Carcinoma
Abstract
Abstract
Hepatocellular Carcinoma (HCC) is the leading cause of cancer deaths worldwide & ranked first among cancers in males and next to breast cancer among females in Egypt based upon results of National Cancer Registry Program of Egypt. "Grabbing the problem from the roots" is the best way to decently describe the use of CRISPR, a special gene editing technique that we will be using to modulate a certain circRNA and adjust its gene expression, which is down-regulated in hepatocellular carcinoma. This in consequence modifies miRNA expression thus amending the mRNA gene expression; which is the visible problem in our trials. This will lead us to adopt a novel strategy for miRNA suppression by using circRNAs. This is accomplished by utilizing a synthetic circuit to give rise to a springboard in our battle against cancer.
